How India’s slow vaccination hurts poor countries, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Of the 2 billion doses that Covax needs to supply to low income countries this year, 1.1 billion doses were to be supplied by the Pune-based Serum Institute of India (SII), comprising Covishield and Novavax. However, the Centre had imposed an unofficial ban on export of all vaccines in March as India suffered from twin blows of low vaccine stocks for its own population and a devastating second wave of Covid-19., Of the 2 billion doses that Covax needs to supply to low income countries this year, 1.1 billion doses were to be supplied by the Pune-based Serum Institute of India (SII), comprising Covishield and Novavax. However, the Centre had imposed an unofficial ban on export of all vaccines in March as India suffered from twin blows of low vaccine stocks for its own population and a devastating second wave of Covid-19., , Read More